| News

Indigo Agriculture opens European headquarters in Basel

17.09.2019

Indigo Agriculture is expanding to Europe and has opened headquarters in Basel to this end. The U.S. company offers pioneering technologies for the agricultural sector. BaselArea.swiss supported Indigo in relocating to Basel.

How can the quality of wheat be tested? (img: pixabay)

Indigo is opening offices in Basel, from where the company’s European business will be managed, as was reported in a press release. Heading up the Europe segment is Georg Goeres, who was previously responsible for  commercial operations and strategy at Basel agrochemical company Syngenta.

Founded in 2013, the company from Boston develops pioneering technologies for the agricultural sector. These include microbiotechnology for seed treatments, techniques for soil sampling, grain quality testing, remote sensing and analytics as well as a digital marketplace for grain transactions.

Indigo has as its objective to work together with farmers and various interest groups in Europe. The aim is to further optimize the supply chain in farming and offer consumers traceable and nutritious products. In future, Indigo intends to get European farmers on board for Indigo Carbon, a program to accelerate carbon sequestration from agricultural soil. It supplements the Terraton Initiative, a global project to remove one trillion metric tons of carbon dioxide from the Earth’s atmosphere and use it to enrich agricultural soils.

„Indigo is leading the movement towards beneficial agriculture. That makes it the most exciting company I have been a part of in my 25-year career,“ commented Georg Goeres.

BaselArea.swiss supported Indigo in relocating to Basel.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

VectivBio secures investments totaling 110 million dollars
Basel Area Business & Innovation, Innovation, Invest

VectivBio secures investments totaling 110 million dollars

The Basel-based biotechnology firm VectivBio has received a capital injection of 110 million US dollars from both new and existing...

Read More
Polyphor receives up to 18 million dollars for development of antibiotics
Basel Area Business & Innovation, Innovation, Invest

Polyphor receives up to 18 million dollars for development of antibiotics

The Allschwil-based company Polyphor has received a second funding award from the global consortium CARB-X to combat antimicrobial resistance. Polyphor...

Read More
What makes Switzerland’s economy resilient in face of COVID pandemic
Basel Area Business & Innovation, Invest

What makes Switzerland’s economy resilient in face of COVID pandemic

The COVID-19 pandemic has hit economies worldwide – and we have not yet overcome it. However, Switzerland is among the...

Read More
DayOne Accelerator applications open
Basel Area Business & Innovation, Innovation

DayOne Accelerator applications open

We are excited to announce the opening of the call for the DayOne Accelerator, now in its 3rd year!

Read More
Matériaux Sabag printing concrete elements
Basel Area Business & Innovation, Innovation, Invest

Matériaux Sabag printing concrete elements

The Jura-based company Matériaux Sabag is now using a 3D printing solution to produce its concrete elements. This approach allows...

Read More
Six companies win the i4Challenge
Basel Area Business & Innovation, Innovation

Six companies win the i4Challenge

The i4Challenge expert jury has selected six winners from 18 finalists. The Industry 4.0 solutions range from 3D printing, IoT,...

Read More
Monte Rosa Therapeutics banks 96 million US dollars
Basel Area Business & Innovation, Innovation, Invest

Monte Rosa Therapeutics banks 96 million US dollars

The Basel-based biotechnology firm Monte Rosa Therapeutics has raised a total of 96 million US dollars after closing a successful...

Read More
Roche launches new coronavirus antibody test
Basel Area Business & Innovation, Innovation, Invest

Roche launches new coronavirus antibody test

Roche is launching on the market a new antibody test to determine coronavirus infections. This should help with the development...

Read More
Investors see great potential in Polyneuron
Basel Area Business & Innovation, Innovation, Invest

Investors see great potential in Polyneuron

The Basel-based company Polyneuron Pharmaceuticals extended its Series A funding round and has now raised a total of 36.5 million...

Read More
Lonza set to manufacture coronavirus drug for Humanigen
Basel Area Business & Innovation, Innovation, Invest

Lonza set to manufacture coronavirus drug for Humanigen

The Basel-based pharmaceutical supplier Lonza is supporting the US firm Humanigen in the development of a potential coronavirus therapeutic. Lonza...

Read More
1 2 3 21

Do you have a question? We'd like to hear from you.